25th BioPharma Drug Discovery Nexus 2026, Zurich
Nygen at the 25th BioPharma Drug Discovery Nexus in Zurich, April 29–30, 2026. Session with Parashar Dhapola on AI agents versus AI workflows for single-cell annotation at scale.
Read more →A curated index of articles, updates, events, and published work across single-cell research.
Nygen at the 25th BioPharma Drug Discovery Nexus in Zurich, April 29–30, 2026. Session with Parashar Dhapola on AI agents versus AI workflows for single-cell annotation at scale.
Read more →
Nygen Analytics wins 1M SEK Vinnova grant to develop AI-powered predictive models for cancer immunotherapy with VLP Therapeutics, advancing personalized treatment selection.
Read more →
CyteType is multi-agentic annotation system designed for single-cell RNA-seq cluster annotation. Designed to deploy three specialized AI agents to provide accurate cell type identification, literature validation, and pathway-level reasoning beyond traditional marker-based methods and beyond. Built for researchers seeking precise, evidence-backed single-cell data analysis with comprehensive biological context.
Read more →
Nygen Analytics, the only single-cell–focused omics data-analytics platform to pair ISO 27001 certification and SOC 2 compliance with full GDPR alignment
Read more →
Explore how ASI transforms drug discovery by harnessing domain-specific models and advanced computing tools for faster, smarter biomedical innovation.
Read more →